ADAMTS13 and thrombotic thrombocytopenic purpura: Insufficient ADAMTS13 activity can lead to unregulated VWF platelet-capturing and is a risk factor for thrombosis including thrombotic thrombocytopenic purpura (TTP), myocardial infarction, stroke, and venous thromboembolism1–4.